ELI LILLY & Co is 216.0x more valuable than Xenon Pharmaceuticals Inc. by market capitalization ($1.072 T vs $4.96 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | XENE | LLY |
|---|---|---|
| Market cap | $4.96 B | $1.072 T |
| US-listed rank | #1390 | #10 |
| Revenue (latest FY) | $311.00K | $65.18B |
| Net income (latest FY) | -$345.91M | $20.64B |
| Net margin | -111225.1% | 31.7% |
| P/E (trailing FY) | - | 51.9 |
| SEC filings | 763 | 989 |
ELI LILLY & Co is 216.0x more valuable than Xenon Pharmaceuticals Inc. by market capitalization ($1.072 T vs $4.96 B).
In their latest fiscal years, Xenon Pharmaceuticals Inc. reported $311.00K in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Xenon Pharmaceuticals Inc. and ELI LILLY & Co, or browse the full rankings.